CorVascular has introduced its new DuplexABI™ solution, which will be showcased at the Society for Vascular Ultrasound 2026 Annual Conference. This innovative tool is designed to streamline the diagnostic process for vascular specialists by combining ankle-brachial index (ABI) testing with duplex ultrasound capabilities in a single, easy-to-use device. The aim is to enhance the efficiency of vascular exams, reduce the complexity of equipment, and allow for more flexible patient assessments in various healthcare settings.

For those interested in maintaining their vascular health, this development could mean quicker and more accurate assessments. The DuplexABI solution allows healthcare providers to perform two essential tests simultaneously, which can lead to faster diagnoses and better treatment decisions. This is particularly beneficial for individuals with vascular concerns, as timely interventions can significantly impact overall health and well-being.

The DuplexABI is a result of collaboration between CorVascular and Terason, leveraging their expertise in vascular diagnostics and ultrasound technology. While the product is set to be demonstrated live at the conference, it is important to note that this is an early-stage rollout aimed at improving clinical workflows. The effectiveness of the DuplexABI in real-world settings will need to be evaluated further as it becomes integrated into practice.

If you’re concerned about your vascular health, staying informed about advancements like DuplexABI can be beneficial. Engaging with healthcare providers who utilize the latest diagnostic tools may help ensure you receive timely and effective care.